{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:32:07Z","timestamp":1791106327531,"version":"4.1.0"},"reference-count":108,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl. 5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2314,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,5]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Liver biopsy plays a central role in treatment algorithms in patients with hepatitis B and remains the gold standard for evaluating hepatic pathology. The pathology of hepatitis B is diverse and reflects the natural history of infection. An acute hepatitic pattern with lobular disarray is seen in acute infection, during acute flares of disease, and with acute hepatitis D superinfection. In chronic hepatitis B, inflammation is less pronounced in the immune-tolerant phase and is prominent during immune-mediated viral clearance. Active inflammation appears to be the driving force for development of fibrosis. Inflammatory grades and fibrosis stage are assigned as is done for hepatitis C. Although current management guidelines recommend liver biopsies only in select patients based on age, viral levels, and hepatitis B e antigen status, these clinical and biochemical parameters do not show consistent correlations with liver histology. Liver biopsy also helps identify preneoplastic lesions including large cell and small cell change. Unlike in other causes of chronic hepatitis, immunostains are widely used and can help determine the phase of infection. Liver biopsies can also identify additional pathology that may contribute to liver disease such as steatohepatitis, iron overload, autoimmune hepatitis, and drug-induced injury. Thus, liver biopsy can play an important role in staging and grading chronic hepatitis B and should be more widely used in assessing the need for therapy. (Hepatology 2009;49:S61\u2013S71.)<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.22930","type":"journal-article","created":{"date-parts":[[2010,7,5]],"date-time":"2010-07-05T12:32:34Z","timestamp":1278333154000},"page":"S61-S71","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":99,"title":["Liver biopsy findings in chronic hepatitis B #"],"prefix":"10.1097","volume":"49","author":[{"given":"Haresh","family":"Mani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Kleiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20241201","first-page":"25","article-title":"Staining methods of Australia antigen in paraffin section-detection of cytoplasmic inclusion bodies.","volume":"44","author":"Shikata","year":"1974","journal-title":"Jpn J Exp Med"},{"key":"R2-9-20241201","first-page":"93","article-title":"Victoria bluenuclear fast red stain for HBs antigen detection in paraffin section.","volume":"31","author":"Tanaka","year":"1981","journal-title":"Acta Pathol Jpn"},{"key":"R3-9-20241201","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1365-2559.1990.tb01122.x","article-title":"Coexistence of hepatocyte groundglass inclusions from several causes.","volume":"16","author":"AlonsoMarti","year":"1990","journal-title":"Histopathology"},{"key":"R4-9-20241201","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/hep.510290230","article-title":"Clinical and histological outcome after hepatitis B e antigen to antibody seroconversion in children with chronic hepatitis B.","volume":"29","author":"RuizMoreno","year":"1999","journal-title":"HEPATOLOGY"},{"key":"R5-9-20241201","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1440-1746.2008.05478.x","article-title":"Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors.","volume":"23","author":"Peng","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"R6-9-20241201","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.3748\/wjg.14.4040","article-title":"Composition of inflammatory infiltrate and its correlation with HBVHCV antigen expression.","volume":"14","author":"WalewskaZielecka","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R7-9-20241201","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1084\/jem.191.8.1269","article-title":"The role of virusspecific CD8() cells in liver damage and viral control during persistent hepatitis B virus infection.","volume":"191","author":"Maini","year":"2000","journal-title":"J Exp Med"},{"key":"R8-9-20241201","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1084\/jem.20072076","article-title":"Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection.","volume":"205","author":"Das","year":"2008","journal-title":"J Exp Med"},{"key":"R9-9-20241201","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1084\/jem.20061287","article-title":"Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cellmediated liver damage.","volume":"204","author":"Dunn","year":"2007","journal-title":"J Exp Med"},{"key":"R10-9-20241201","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/hep.21844","article-title":"The phenotype of hepatitis B virusspecific T cells differ in the liver and blood in chronic hepatitis B virus infection.","volume":"46","author":"Chang","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R11-9-20241201","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/01.mcg.0000248000.42581.35","article-title":"Peripheral blood lymphocyte populations in endstage liver diseases.","volume":"41","author":"Romo","year":"2007","journal-title":"J Clin Gastroenterol"},{"key":"R12-9-20241201","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/j.1440-1746.2007.04849.x","article-title":"Correlation of hepatitis B core antigen and betacatenin expression on hepatocytes in chronic hepatitis B virus infection: relevance to the severity of liver damage and viral replication.","volume":"22","author":"Kim","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"R13-9-20241201","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S1473-3099(07)70289-X","article-title":"Tcell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies.","volume":"7","author":"Manigold","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"R14-9-20241201","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11904-008-0017-1","article-title":"Evaluation and treatment of the patient coinfected with hepatitis B and HIV.","volume":"5","author":"Kitchell","year":"2008","journal-title":"Curr HIVAIDS Rep"},{"key":"R15-9-20241201","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1440-1746.2006.04547.x","article-title":"Comparison of liver histopathology between chronic hepatitis C patients and chronic hepatitis B and Ccoinfected patients.","volume":"22","author":"Lee","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"R16-9-20241201","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s15010-004-3080-6","article-title":"Influence of chronic coinfection with hepatitis B and C virus on liver histology.","volume":"32","author":"Sagnelli","year":"2004","journal-title":"Infection"},{"key":"R17-9-20241201","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/(SICI)1096-9071(199907)58:3<201::AID-JMV3>3.0.CO;2-2","article-title":"Serologically silent hepatitis B virus coinfection in patients with hepatitis C virusassociated chronic liver disease: clinical and virological significance.","volume":"58","author":"Fukuda","year":"1999","journal-title":"J Med Virol"},{"key":"R18-9-20241201","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0168-8278(02)00413-0","article-title":"A comparison of fibrosis progression in chronic liver diseases.","volume":"38","author":"Poynard","year":"2003","journal-title":"J Hepatol"},{"key":"R19-9-20241201","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.dld.2006.01.020","article-title":"Hepatotoxicity and antiretroviral therapy with protease inhibitors: a review.","volume":"38","author":"Bruno","year":"2006","journal-title":"Dig Liver Dis"},{"key":"R20-9-20241201","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/QAI.0b013e31814be887","article-title":"Natural history of compensated viral cirrhosis in a cohort of patients with HIV infection.","volume":"46","author":"Bruno","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R21-9-20241201","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00126334-200303010-00004","article-title":"Severe hepatotoxicity during combination antiretroviral treatment: incidence, liver histology, and outcome.","volume":"32","author":"Puoti","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R22-9-20241201","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1086\/511867","article-title":"Impact of hepatitis D virus infection on the longterm outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.","volume":"44","author":"Sheng","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R23-9-20241201","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/hep.510310136","article-title":"Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond.","volume":"31","author":"Brunt","year":"2000","journal-title":"HEPATOLOGY"},{"key":"R24-9-20241201","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1089-3261(02)00009-0","article-title":"Scoring of chronic hepatitis.","volume":"6","author":"Scheuer","year":"2002","journal-title":"Clin Liver Dis"},{"key":"R25-9-20241201","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.dld.2005.04.030","article-title":"Spontaneous regression of hepatitis B virusassociated cirrhosis developed in childhood.","volume":"37","author":"Bortolotti","year":"2005","journal-title":"Dig Liver Dis"},{"key":"R26-9-20241201","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1053\/j.gastro.2004.03.017","article-title":"Longterm benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis.","volume":"126","author":"Farci","year":"2004","journal-title":"Gastroenterology"},{"key":"R27-9-20241201","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jhep.2005.07.036","article-title":"Histologicalhemodynamic correlation in cirrhosisa histological classification of the severity of cirrhosis.","volume":"44","author":"Nagula","year":"2006","journal-title":"J Hepatol"},{"key":"R28-9-20241201","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0168-8278(02)00357-4","article-title":"Histopathological study of chronic hepatitis B and C: a comparison of two scoring systems.","volume":"38","author":"Rozario","year":"2003","journal-title":"J Hepatol"},{"key":"R29-9-20241201","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jhep.2007.07.006","article-title":"Grading and staging systems for inflammation and fibrosis in chronic liver diseases.","volume":"47","author":"Goodman","year":"2007","journal-title":"J Hepatol"},{"key":"R30-9-20241201","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0168-8278(03)00171-5","article-title":"Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B.","volume":"39","author":"Myers","year":"2003","journal-title":"J Hepatol"},{"key":"R31-9-20241201","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1572-0241.2005.41289.x","article-title":"Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model.","volume":"100","author":"Hui","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R32-9-20241201","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/hep.20935","article-title":"A novel panel of blood markers to assess the degree of liver fibrosis.","volume":"42","author":"Cales","year":"2005","journal-title":"HEPATOLOGY"},{"key":"R33-9-20241201","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1478-3231.2006.01287.x","article-title":"Noninvasive models for predicting histology in patients with chronic hepatitis B.","volume":"26","author":"Wai","year":"2006","journal-title":"Liver Int"},{"key":"R34-9-20241201","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/00042737-200210000-00015","article-title":"Prothrombin index is an indirect marker of severe liver fibrosis.","volume":"14","author":"Croquet","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R35-9-20241201","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2036.2007.03400.x","article-title":"Epidemiology of chronic hepatitis B infection in France: risk factors for significant fibrosis-results of a nationwide survey.","volume":"26","author":"Cadranel","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R36-9-20241201","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1111\/j.1572-0241.2006.00788.x","article-title":"Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis Bvirus related liver disease.","volume":"101","author":"Mohamadnejad","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R37-9-20241201","first-page":"34","article-title":"Color Doppler velocity profile and contrastenhanced ultrasonography in assessment of liver cirrhosis.","volume":"7","author":"Lin","year":"2008","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"R38-9-20241201","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jhep.2008.02.008","article-title":"Noninvasive evaluation of liver fibrosis using transient elastography.","volume":"48","author":"Castera","year":"2008","journal-title":"J Hepatol"},{"key":"R39-9-20241201","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/jmri.21227","article-title":"Chronic hepatitis: role of diffusionweighted imaging and diffusion tensor imaging for the diagnosis of liver fibrosis and inflammation.","volume":"28","author":"Taouli","year":"2008","journal-title":"J Magn Reson Imaging"},{"key":"R40-9-20241201","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/hep.22200","article-title":"Transient elastography in acute hepatitis: All thats stiff is not fibrosis.","volume":"47","author":"Cobbold","year":"2008","journal-title":"HEPATOLOGY"},{"key":"R41-9-20241201","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1582-4934.2007.00092.x","article-title":"Biomarkers of hepatic fibrosis, fibrogenesis and genetic predisposition pending between fiction and reality.","volume":"11","author":"Gressner","year":"2007","journal-title":"J Cell Mol Med"},{"key":"R42-9-20241201","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/jcp.53.7.541","article-title":"A survey of liver pathology in needle biopsies from HBsAg and antiHBe positive individuals.","volume":"53","author":"ter Borg","year":"2000","journal-title":"J Clin Pathol"},{"key":"R43-9-20241201","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0016-5085(88)90509-4","article-title":"Ultrasoundassisted percutaneous liver biopsy: superiority of the TruCut over the Menghini needle for diagnosis of cirrhosis.","volume":"95","author":"Colombo","year":"1988","journal-title":"Gastroenterology"},{"key":"R44-9-20241201","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1572-0241.2007.01110.x","article-title":"Liver biopsy in cirrhotic patients.","volume":"102","author":"Sherman","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R45-9-20241201","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3748\/wjg.v13.i1.74","article-title":"Hepatitis B virusinduced oncogenesis.","volume":"13","author":"Lupberger","year":"2007","journal-title":"World J Gastroenterol"},{"key":"R46-9-20241201","first-page":"711","article-title":"Correlative analysis of histological profile of the adjoining liver parenchyma with liver enzyme levels in hepatocellular carcinoma and their comparison with chronic liver disease in autopsy cases.","volume":"50","author":"Vaiphei","year":"2007","journal-title":"Indian J Pathol Microbiol"},{"key":"R47-9-20241201","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1572-0241.2006.00364.x","article-title":"Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma.","volume":"101","author":"Cantarini","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R48-9-20241201","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/jcp.26.3.217","article-title":"Liver cell dysplasia: a premalignant condition.","volume":"26","author":"Anthony","year":"1973","journal-title":"J Clin Pathol"},{"key":"R49-9-20241201","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1002\/1097-0142(19830615)51:12<2197::AID-CNCR2820511208>3.0.CO;2-5","article-title":"Morphologic studies of the liver cell dysplasia.","volume":"51","author":"Watanabe","year":"1983","journal-title":"Cancer"},{"key":"R50-9-20241201","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/jcp.48.5.470","article-title":"Membrane staining for hepatitis B surface antigen on hepatocytes: a sensitive and specific marker of active viral replication in hepatitis B.","volume":"48","author":"Chu","year":"1995","journal-title":"J Clin Pathol"},{"key":"R51-9-20241201","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/0046-8177(92)90126-N","article-title":"Liver cell dysplasia: a DNA aneuploid lesion with distinct morphologic features.","volume":"23","author":"Thomas","year":"1992","journal-title":"Hum Pathol"},{"key":"R52-9-20241201","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0168-8278(97)80177-8","article-title":"Interphase cytogenetic analysis reveals numerical chromosome aberrations in large liver cell dysplasia.","volume":"27","author":"Terris","year":"1997","journal-title":"J Hepatol"},{"key":"R53-9-20241201","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1046\/j.1365-2559.2001.01172.x","article-title":"Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with noncirrhotic and cirrhotic chronic viral hepatitis.","volume":"39","author":"Libbrecht","year":"2001","journal-title":"Histopathology"},{"key":"R54-9-20241201","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00000478-199703000-00007","article-title":"Largecell change of hepatocytes in cirrhosis may represent a reaction to prolonged cholestasis.","volume":"21","author":"Natarajan","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"R55-9-20241201","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/hep.510260607","article-title":"Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched casecontrol study, pathological analysis, and pathogenetic hypothesis.","volume":"26","author":"Lee","year":"1997","journal-title":"HEPATOLOGY"},{"key":"R56-9-20241201","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/MCG.0b013e318038159d","article-title":"Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with chronic hepatitis B.","volume":"42","author":"Koo","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"R57-9-20241201","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/0016-5085(90)90811-E","article-title":"Detection of hepatitis B virus antigens in liver tissue. A relation to viral replication and histology in chronic hepatitis B infection.","volume":"99","author":"Naoumov","year":"1990","journal-title":"Gastroenterology"},{"key":"R58-9-20241201","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0168-8278(02)00004-1","article-title":"Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers.","volume":"36","author":"MartinotPeignoux","year":"2002","journal-title":"J Hepatol"},{"key":"R59-9-20241201","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1365-2893.2006.00781.x","article-title":"Nuclear HBcAg and histology activity index as independent predictors of the expression of singly spliced HBVRNA.","volume":"14","author":"Sheen","year":"2007","journal-title":"J Viral Hepat"},{"key":"R60-9-20241201","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0016-5085(87)90863-8","article-title":"Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection. Hepatocyte with cytoplasmicmembranous hepatitis B core antigen as a possible target for immune hepatocytolysis.","volume":"92","author":"Chu","year":"1987","journal-title":"Gastroenterology"},{"key":"R61-9-20241201","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/0016-5085(95)90760-2","article-title":"Subcellular localization of hepatitis B core antigen in relation to hepatocyte regeneration in chronic hepatitis B.","volume":"109","author":"Chu","year":"1995","journal-title":"Gastroenterology"},{"key":"R62-9-20241201","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1478-3231.1999.tb00036.x","article-title":"Cytoplasmic expression of hepatitis B core antigen in chronic hepatitis B virus infection: role of precore stop mutants.","volume":"19","author":"Park","year":"1999","journal-title":"Liver"},{"key":"R63-9-20241201","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1478-3231.1999.tb00052.x","article-title":"HBeAg immunostaining of liver tissue in various stages of chronic hepatitis B.","volume":"19","author":"Lindh","year":"1999","journal-title":"Liver"},{"key":"R64-9-20241201","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/hep.1840140106","article-title":"HBxAg in the liver from carrier patients with chronic hepatitis and cirrhosis.","volume":"14","author":"Wang","year":"1991","journal-title":"HEPATOLOGY"},{"key":"R65-9-20241201","first-page":"4971","article-title":"Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer.","volume":"51","author":"Wang","year":"1991","journal-title":"Cancer Res"},{"key":"R66-9-20241201","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0168-8278(01)00073-3","article-title":"Intense isolated expression with preS1 (large protein) antibodies in the liver graft associated with severe acute hepatitis B virus reactivation.","volume":"34","author":"DuclosVallee","year":"2001","journal-title":"J Hepatol"},{"key":"R67-9-20241201","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1600-0676.1992.tb01052.x","article-title":"In situ hybridization in viral hepatitis.","volume":"12","author":"Negro","year":"1992","journal-title":"Liver"},{"key":"R68-9-20241201","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0168-8278(05)80572-0","article-title":"Identification of hepatitis B virusDNA in the liver by in situ hybridization using a biotinylated probe. Relation to HBcAg expression and histology.","volume":"19","author":"Naoumov","year":"1993","journal-title":"J Hepatol"},{"key":"R69-9-20241201","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1742-1241.2007.01675.x","article-title":"Expression of ckit protooncogen in hepatitis B virusinduced chronic hepatitis, cirrhosis and hepatocellular carcinoma: has it a diagnostic role?","volume":"62","author":"Kara","year":"2008","journal-title":"Int J Clin Pract"},{"key":"R70-9-20241201","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/modpathol.3800554","article-title":"Association of Ecadherin, matrix metalloproteinases, and tissue inhibitors of metalloproteinases with the progression and metastasis of hepatocellular carcinoma.","volume":"19","author":"Gao","year":"2006","journal-title":"Mod Pathol"},{"key":"R71-9-20241201","first-page":"81","article-title":"Hepatocellular dysplastic nodules.","volume":"79","author":"Roncalli","year":"2008","journal-title":"Ann Ital Chir"},{"key":"R72-9-20241201","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S1089-3261(02)00012-0","article-title":"The role of immunohistochemistry in diagnosis.","volume":"6","author":"Roskams","year":"2002","journal-title":"Clin Liver Dis"},{"key":"R73-9-20241201","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hep.21513","article-title":"Chronic hepatitis B.","volume":"45","author":"Lok","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R74-9-20241201","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/hep.22476","article-title":"Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States.","volume":"48","author":"Tong","year":"2008","journal-title":"HEPATOLOGY"},{"key":"R75-9-20241201","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/lt.20328","article-title":"Histopathology and clinical correlates of endstage hepatitis B cirrhosis: a possible mechanism to explain the response to antiviral therapy.","volume":"11","author":"Sigal","year":"2005","journal-title":"Liver Transpl"},{"key":"R76-9-20241201","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s00535-008-2183-8","article-title":"Fibrosis progression rates between chronic hepatitis B and C patients with elevated alanine aminotransferase levels.","volume":"43","author":"Fujiwara","year":"2008","journal-title":"J Gastroenterol"},{"key":"R77-9-20241201","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2893.2008.00989.x","article-title":"High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels.","volume":"15","author":"Park","year":"2008","journal-title":"J Viral Hepat"},{"key":"R78-9-20241201","first-page":"159","article-title":"Asymptomatic chronic hepatitis B virus infection in northern India.","volume":"26","author":"Dixit","year":"2007","journal-title":"Indian J Gastroenterol"},{"key":"R79-9-20241201","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1053\/j.gastro.2008.02.075","article-title":"Virologic and histologic features of chronic hepatitis B virusinfected asymptomatic patients with persistently normal ALT.","volume":"134","author":"Kumar","year":"2008","journal-title":"Gastroenterology"},{"key":"R80-9-20241201","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cgh.2008.02.037","article-title":"Significant prevalence of histologic disease in patients with chronic hepatitis B and mildly elevated serum alanine aminotransferase levels.","volume":"6","author":"Tsang","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R81-9-20241201","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jhep.2007.07.022","article-title":"The clinical significance of persistently normal ALT in chronic hepatitis B infection.","volume":"47","author":"Lai","year":"2007","journal-title":"J Hepatol"},{"key":"R82-9-20241201","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.cgh.2007.01.005","article-title":"Chronic hepatitis B virus carriers in the immunotolerant phase of infection: histologic findings and outcome.","volume":"5","author":"Andreani","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R83-9-20241201","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/hep.21724","article-title":"Natural history and disease progression in Chinese chronic hepatitis B patients in immunetolerant phase.","volume":"46","author":"Hui","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R84-9-20241201","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2893.2005.00692.x","article-title":"Multicentre study of hepatitis B virus genotypes in France: correlation with liver fibrosis and hepatitis B e antigen status.","volume":"13","author":"Halfon","year":"2006","journal-title":"J Viral Hepat"},{"key":"R85-9-20241201","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/00365540410026031","article-title":"Predictive factors and virological response to interferon treatment in children with chronic hepatitis B.","volume":"37","author":"Soderstrom","year":"2005","journal-title":"Scand J Infect Dis"},{"key":"R86-9-20241201","first-page":"487","article-title":"Histologic activity of childhood chronic hepatitis B related to viremia levels, genotypes, mutations, and epidemiologic factors.","volume":"35","author":"Soderstrom","year":"2002","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R87-9-20241201","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/jcp.2007.050765","article-title":"Quantification of intrahepatic total hepatitis B virus DNA in chronic hepatitis B patients and its relationship with liver histology.","volume":"61","author":"Bayram","year":"2008","journal-title":"J Clin Pathol"},{"key":"R88-9-20241201","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MCG.0b013e31803238c6","article-title":"Correlation between hepatitis B virus DNA levels and liver histology: is the controversy because of paucity of data?","volume":"41","author":"Verma","year":"2007","journal-title":"J Clin Gastroenterol"},{"key":"R89-9-20241201","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/00042737-200606000-00013","article-title":"Hepatitis B virus genotypes in children with chronic hepatitis B in Poland.","volume":"18","author":"DzierzanowskaFangrat","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R90-9-20241201","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/jmv.20545","article-title":"Significance of hepatitis B virus genotypes A to E in a cohort of patients with chronic hepatitis B in the Seine Saint Denis District of Paris (France).","volume":"78","author":"GanneCarrie","year":"2006","journal-title":"J Med Virol"},{"key":"R91-9-20241201","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2893.2005.00657.x","article-title":"Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China.","volume":"12","author":"Zeng","year":"2005","journal-title":"J Viral Hepat"},{"key":"R92-9-20241201","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/jhep.2003.50036","article-title":"Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease.","volume":"37","author":"Sumi","year":"2003","journal-title":"HEPATOLOGY"},{"key":"R93-9-20241201","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/gut.2007.139410","article-title":"Chronic viral hepatitis in children: any role for the pathologist?","volume":"57","author":"Guido","year":"2008","journal-title":"Gut"},{"key":"R94-9-20241201","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa021812","article-title":"Adefovir dipivoxil for the treatment of hepatitis B e antigennegative chronic hepatitis B.","volume":"348","author":"Hadziyannis","year":"2003","journal-title":"N Engl J Med"},{"key":"R95-9-20241201","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa020681","article-title":"Adefovir dipivoxil for the treatment of hepatitis B e antigenpositive chronic hepatitis B.","volume":"348","author":"Marcellin","year":"2003","journal-title":"N Engl J Med"},{"key":"R96-9-20241201","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMoa051285","article-title":"A comparison of entecavir and lamivudine for HBeAgpositive chronic hepatitis B.","volume":"354","author":"Chang","year":"2006","journal-title":"N Engl J Med"},{"key":"R97-9-20241201","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa051287","article-title":"Entecavir versus lamivudine for patients with HBeAgnegative chronic hepatitis B.","volume":"354","author":"Lai","year":"2006","journal-title":"N Engl J Med"},{"key":"R98-9-20241201","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/hep.510260634","article-title":"A randomized, controlled trial of a 24month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum.","volume":"26","author":"Lampertico","year":"1997","journal-title":"HEPATOLOGY"},{"key":"R99-9-20241201","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/hep.20128","article-title":"Longterm followup of alphainterferon treatment of patients with chronic hepatitis B.","volume":"39","author":"van Zonneveld","year":"2004","journal-title":"HEPATOLOGY"},{"key":"R100-9-20241201","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00000478-200606000-00008","article-title":"Endotheliitis in chronic viral hepatitis: a comparison with acute cellular rejection and nonalcoholic steatohepatitis.","volume":"30","author":"Yeh","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R101-9-20241201","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.humpath.2007.12.014","article-title":"An immunohistochemical evaluation of C4d deposition in pediatric inflammatory liver diseases.","volume":"39","author":"BouronDal Soglio","year":"2008","journal-title":"Hum Pathol"},{"key":"R102-9-20241201","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/0168-8278(95)80116-2","article-title":"Fibrosing cholestatic hepatitis in a renal transplant recipient associated with the hepatitis B virus precore mutant.","volume":"22","author":"Booth","year":"1995","journal-title":"J Hepatol"},{"key":"R103-9-20241201","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/0016-5085(94)90557-6","article-title":"Fibrosing cholestatic hepatitis in a hepatitis B surface antigen carrier after renal transplantation.","volume":"107","author":"Chen","year":"1994","journal-title":"Gastroenterology"},{"key":"R104-9-20241201","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/0140-6736(93)92160-U","article-title":"Fibrosing cholestatic hepatitis in patient with HIV and hepatitis B.","volume":"342","author":"Fang","year":"1993","journal-title":"Lancet"},{"key":"R105-9-20241201","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/0016-5085(93)90910-5","article-title":"Fibrosing cholestatic hepatitis in a transplant recipient with hepatitis B virus precore mutant.","volume":"105","author":"Fang","year":"1993","journal-title":"Gastroenterology"},{"key":"R106-9-20241201","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/hep.1840130122","article-title":"Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis.","volume":"13","author":"Davies","year":"1991","journal-title":"HEPATOLOGY"},{"key":"R107-9-20241201","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0046-8177(99)90298-8","article-title":"Fibrosiscirrhosis after orthotopic liver transplantation.","volume":"30","author":"Tabatabai","year":"1999","journal-title":"Hum Pathol"},{"key":"R108-9-20241201","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1002\/lt.20946","article-title":"Histologic findings in recurrent HBV.","volume":"12","author":"Thung","year":"2006","journal-title":"Liver Transpl"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.22930","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200905001-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T13:11:14Z","timestamp":1733058674000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200905001-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":108,"journal-issue":{"issue":"Suppl. 5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.22930","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}